Jie Jin, MD, PhD
Zhejiang University · First Affiliated Hospital of Zhejiang University · The First Affiliated Hospital of Zhejiang University Medical College (Hematology)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jie Jin, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:15 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05650580 · TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid TumorsTarapeutics Science Inc. · unknown · Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor · principal investigator
- Ph3NCT05586074 · HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AMLSunshine Lake Pharma Co., Ltd. · recruiting · Leukemia, Acute Myeloid (AML) · principal investigator
- Ph3NCT05236621 · A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple MyelomaQilu Pharmaceutical Co., Ltd. · unknown · Multiple Myeloma, Recurrent or Refractory · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.